Condition
Chondrosarcomas
Total Trials
5
Recruiting
1
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (2)
Trial Status
Completed3
Active Not Recruiting1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07315542RecruitingPrimary
Diagnostic and Therapeutic Targets in Cartilaginous Tumours
NCT01449149Not ApplicableCompleted
Proton Radiation for Chordomas and Chondrosarcomas
NCT02389244Phase 2Active Not Recruiting
A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas
NCT00401388Phase 2CompletedPrimary
A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas
NCT00797602Completed
Proton Therapy for Chordomas and/or Chondrosarcomas
Showing all 5 trials